标题
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 26, Pages 15182-15192
出版商
Proceedings of the National Academy of Sciences
发表日期
2020-06-18
DOI
10.1073/pnas.1922072117
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs
- (2018) Elimelech Nesher et al. CANCER RESEARCH
- Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy
- (2017) Jop C. Teepen et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Pluripotent Stem Cell Differentiation into Functional Epicardial Progenitor Cells
- (2017) Juan Antonio Guadix et al. Stem Cell Reports
- MUSCLEMOTION
- (2017) Luca Sala et al. CIRCULATION RESEARCH
- New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
- (2016) Alberto A. Gabizon et al. DRUG RESISTANCE UPDATES
- Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study
- (2016) Tara O. Henderson et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry
- (2015) Erik Hulegårdh et al. AMERICAN JOURNAL OF HEMATOLOGY
- Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia
- (2015) Qi Qu et al. LEUKEMIA RESEARCH
- Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia
- (2015) Limin Liu et al. LEUKEMIA RESEARCH
- Chemical profiling of the genome with anti-cancer drugs defines target specificities
- (2015) Baoxu Pang et al. Nature Chemical Biology
- Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors
- (2015) Elżbieta Sadurska PEDIATRIC CARDIOLOGY
- Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
- (2014) Terrence N. Wong et al. NATURE
- Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up
- (2014) Olga Lenčová-Popelová et al. PLoS One
- Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
- (2013) Marzia Lotrionte et al. AMERICAN JOURNAL OF CARDIOLOGY
- Doxorubicin Enhances Nucleosome Turnover around Promoters
- (2013) Fan Yang et al. CURRENT BIOLOGY
- Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts
- (2013) Sheng Zhao et al. Journal of Cardiology
- Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial
- (2013) Jie Jin et al. LANCET ONCOLOGY
- Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
- (2013) Baoxu Pang et al. Nature Communications
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome
- (2011) Guoqing Wei et al. Journal of Hematology & Oncology
- Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
- (2010) M. Aapro et al. ANNALS OF ONCOLOGY
- The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
- (2010) S. Kayser et al. BLOOD
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- A robust xenotransplantation model for acute myeloid leukemia
- (2009) P V Sanchez et al. LEUKEMIA
- Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies
- (2008) D. Rayson et al. ANNALS OF ONCOLOGY
- Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta
- (2008) Sari Neijenhuis et al. DNA REPAIR
- Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy
- (2008) Elke Martin et al. TOXICOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now